首页> Biomolecules & therapeutics> Selonsertib, an ASK1 Inhibitor, Ameliorates Ovalbumin-Induced Allergic Asthma during Challenge and Sensitization Periods.

Selonsertib, an ASK1 Inhibitor, Ameliorates Ovalbumin-Induced Allergic Asthma during Challenge and Sensitization Periods.

导出 OA

翻译打印收藏纠错

第一作者： So-Young,Han

第一单位： Department of Fundamental Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02446, Republic of Korea.

作者： So-Young,Han ^[1] ; Dong-Soon,Im ^[1]

作者单位： Department of Fundamental Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02446, Republic of Korea. ^[1]

关键词 Allergy Apoptosis signal-regulating kinase 1 Asthma Immunopharmacology Selonsertib

DOI 10.4062/biomolther.2023.203

PMID 38844790

发布时间 2024-07-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomolecules & therapeutics

2024年32卷4期

451-459页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Biomolecules & therapeutics

2024年32卷4期

451-459页

检索历史清除

Selonsertib, an ASK1 Inhibitor, Ameliorates Ovalbumin-Induced Allergic Asthma during Challenge and Sensitization Periods.

Biomolecules & therapeutics

相似文献

同项目论文

Biomolecules & therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Selonsertib, an ASK1 Inhibitor, Ameliorates Ovalbumin-Induced Allergic Asthma during Challenge and Sensitization Periods.

Biomolecules & therapeutics

相似文献

同项目论文

Biomolecules & therapeutics

相关期刊

检索历史清除